The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...
The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.
The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback